Paul-Ehrlich-Institut
Research ServicesHesse, Germany201-500 Employees
The Paul-Ehrlich-Institut is Germany’s Federal Institute for Vaccines and Biomedicines, combining regulatory responsibilities with active biomedical research. Based near Frankfurt in Langen, it operates under the Federal Ministry of Health and conducts research on biomedicines for humans and veterinary immunological products while also granting authorisations when benefits outweigh risks. The institute oversees clinical trial approvals, pharmacovigilance, official batch testing, scientific advice, and inspections, supporting public health through rigorous evaluation and monitoring of medicinal products. In addition to its regulatory duties, it engages in independent experimental research that informs and underpins its regulatory activities, aiming to improve access to safe, effective, and high-quality biomedicines. The organization collaborates with international bodies and contributes expert guidance to entities such as the WHO, EMA, and the European Commission, reflecting its dual role in science and regulation. A recent collaboration highlighted its ongoing international engagement, exemplified by partnerships and joint projects with global health organizations. The institute employs staff across its research and regulatory functions, reflecting its broad scope and public health mandate. } ) } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }